Mama, Alsaiman M.
HRN: 12-88-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/08/2023
08/15/2023
IV
1g
Q6hours
T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes